%0 Journal Article
%T Treatment With Grazoprevir/Elbasvir for Renal Transplant Recipients With Chronic Hepatitis C Virus Infection and Impaired Allograft Function
%A Andreas Kribben
%A Guido Gerken
%A Hana Guberina
%A Justa Friebus-Kardash
%A Katharina Willuweit
%A Kerstin Herzer
%A Oliver Witzke
%A Ute Eisenberger
%J Archive of "Transplantation Direct".
%D 2019
%R 10.1097/TXD.0000000000000860
%X Direct-acing antiviral agents are highly efficient treatment options for chronic hepatitis C virus (HCV) infection after renal allograft transplantation. Treatment options for patients with impaired graft function remain limited. Therefore, we assessed the effectiveness and safety of grazoprevir/elbasvir therapy for patients with chronic HCV infection and impaired renal allograft function
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6324915/